Patents by Inventor Sunghyouk PARK

Sunghyouk PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER, FOR DIAGNOSING PANCREATIC CANCER, COMPRISING ASPROSIN, AND USE THEREOF
    Publication number: 20240036049
    Abstract: A biomarker, for diagnosing pancreatic cancer, including asprosin, and the use thereof, has been confirmed that: the survival prognosis of a pancreatic cancer patient is worse in the case of a higher expression of FBN-1 gene encoding fibrillin-1 which is the precursor of asprosin in a clinical information database; an asprosin level at a cell level is related to an occurrence of pancreatic cancer; and the asprosin level in the blood of a pancreatic cancer patient or an early stage pancreatic cancer patient is higher than that of a healthy person.
    Type: Application
    Filed: April 8, 2021
    Publication date: February 1, 2024
    Applicants: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, INHA-INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Sunghyouk PARK, Sunmi KANG, Hoonsik NAM, Soon Sun HONG, Kyung Hee JUNG